Adderall 5

   
Google
 
Web NewDrugInformation.com

Adderall 5


Drug - Adderall 5
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate
Multiple ingredients are in alphabetical order.

Strength - 1.25MG;1.25MG;1.25MG;1.25MG
The potency of the active ingredient(s), Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate. May repeat for multiple part products.

Applicant - SHIRE
The firm name holding legal responsibility for Adderall 5. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 011522
The FDA assigned number to Adderall 5. Format is nnnnnn.

Product Number - 009
The FDA assigned number to identify Adderall 5. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 12, 1997
The date Adderall 5 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Adderall 5. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Adderall 5 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Shire Development Inc
The full name of the firm holding legal responsibility for the new application of Adderall 5.

Adderall 5